[
    {
        "data": {
            "doi": "10.1002/cca.3581",
            "question": "Can weight loss interventions improve outcomes for overweight and obese breast cancer survivors?",
            "gold_answer": "Low\u2010certainty evidence suggests that weight loss interventions, particularly those that include a combination of diet, exercise, and psychological support, lead to a reduction in body weight of about 2 kg, a reduction in body mass index of about 1 kg/m 2 , and important improvements in quality of life among overweight and obese breast cancer survivors. Reviewers found no data about the effects of weight loss interventions on breast cancer recurrence or survival.",
            "gold_answer_terms": "CANCER (cancer): A disease of the cells.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3581",
            "llm_answer": "Yes, weight loss interventions can improve outcomes for overweight and obese breast cancer survivors. Studies have shown that weight loss can reduce the risk of breast cancer recurrence and improve overall survival in this population. Additionally, weight loss can also improve other health outcomes, such as reducing the risk of developing chronic diseases like diabetes and cardiovascular disease, which are common in breast cancer survivors.\nA 2019 systematic review and meta-analysis published in the Journal of Clinical Oncology found that weight loss interventions were associated with significant improvements in breast cancer outcomes, including reduced risk of recurrence and improved overall survival. Another study published in the Journal of the National Cancer Institute in 2018 found that a 5% or greater weight loss was associated with a 34% reduction in the risk of breast cancer recurrence in postmenopausal women.\nIt's important to note that weight loss interventions should be tailored to the individual patient and may include a combination of diet, exercise, and behavior modification. It's also important to consult with a healthcare provider before starting any weight loss program, especially for breast cancer survivors who may have unique health needs.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> Can weight loss interventions improve outcomes for overweight and obese breast cancer survivors?[/INST]",
            "topic1": [
                "cancers",
                "endocrine metabolic"
            ],
            "topic2": [
                "obesity",
                "breast cancer"
            ],
            "year": 2021,
            "author": "Gupta, Adarsh"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 101,
                            "score": 0.5,
                            "text": "Yes, weight loss interventions can improve outcomes for overweight and obese breast cancer survivors.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 102,
                            "end": 234,
                            "score": 0.5,
                            "text": "Studies have shown that weight loss can reduce the risk of breast cancer recurrence and improve overall survival in this population.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 235,
                            "end": 444,
                            "score": 0.5,
                            "text": "Additionally, weight loss can also improve other health outcomes, such as reducing the risk of developing chronic diseases like diabetes and cardiovascular disease, which are common in breast cancer survivors.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 445,
                            "end": 711,
                            "score": 0.5,
                            "text": "A 2019 systematic review and meta-analysis published in the Journal of Clinical Oncology found that weight loss interventions were associated with significant improvements in breast cancer outcomes, including reduced risk of recurrence and improved overall survival.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 712,
                            "end": 931,
                            "score": 0.5,
                            "text": "Another study published in the Journal of the National Cancer Institute in 2018 found that a 5% or greater weight loss was associated with a 34% reduction in the risk of breast cancer recurrence in postmenopausal women.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt0_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 932,
                            "end": 1106,
                            "score": 0.5,
                            "text": "It's important to note that weight loss interventions should be tailored to the individual patient and may include a combination of diet, exercise, and behavior modification.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt0_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1107,
                            "end": 1278,
                            "score": 0.5,
                            "text": "It's also important to consult with a healthcare provider before starting any weight loss program, especially for breast cancer survivors who may have unique health needs.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3581",
            "question": "Can weight loss interventions improve outcomes for overweight and obese breast cancer survivors?",
            "gold_answer": "Low\u2010certainty evidence suggests that weight loss interventions, particularly those that include a combination of diet, exercise, and psychological support, lead to a reduction in body weight of about 2 kg, a reduction in body mass index of about 1 kg/m 2 , and important improvements in quality of life among overweight and obese breast cancer survivors. Reviewers found no data about the effects of weight loss interventions on breast cancer recurrence or survival.",
            "gold_answer_terms": "CANCER (cancer): A disease of the cells.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3581",
            "llm_answer": "Yes, weight loss interventions can improve outcomes for overweight and obese breast cancer survivors. Studies have shown that weight loss can reduce the risk of breast cancer recurrence and improve overall survival rates for breast cancer patients who are overweight or obese. Additionally, weight loss can also improve other health outcomes, such as reducing the risk of heart disease, diabetes, and other chronic conditions.\nIt's important to note that weight loss interventions should be tailored to the individual patient and should include a combination of diet, exercise, and behavior modification. It's also important to consult with a healthcare provider before starting any weight loss program, especially for breast cancer survivors who may have specific health needs and concerns.\nIt's also important to note that weight loss should not be the only focus, it's important to also consider other factors such as overall healthy lifestyle habits, stress management, and mental health support.\nIt's also important to note that weight loss interventions should be sensitive to the individual's body image and should not promote unhealthy or unrealistic weight loss goals. It's important to focus on healthy habits rather than weight loss.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> Can weight loss interventions improve outcomes for overweight and obese breast cancer survivors?[/INST]",
            "topic1": [
                "cancers",
                "endocrine metabolic"
            ],
            "topic2": [
                "obesity",
                "breast cancer"
            ],
            "year": 2021,
            "author": "Gupta, Adarsh"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 101,
                            "score": 0.5,
                            "text": "Yes, weight loss interventions can improve outcomes for overweight and obese breast cancer survivors.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 102,
                            "end": 276,
                            "score": 0.5,
                            "text": "Studies have shown that weight loss can reduce the risk of breast cancer recurrence and improve overall survival rates for breast cancer patients who are overweight or obese.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 277,
                            "end": 426,
                            "score": 0.5,
                            "text": "Additionally, weight loss can also improve other health outcomes, such as reducing the risk of heart disease, diabetes, and other chronic conditions.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 427,
                            "end": 604,
                            "score": 0.5,
                            "text": "It's important to note that weight loss interventions should be tailored to the individual patient and should include a combination of diet, exercise, and behavior modification.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 605,
                            "end": 791,
                            "score": 0.5,
                            "text": "It's also important to consult with a healthcare provider before starting any weight loss program, especially for breast cancer survivors who may have specific health needs and concerns.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 792,
                            "end": 1000,
                            "score": 0.5,
                            "text": "It's also important to note that weight loss should not be the only focus, it's important to also consider other factors such as overall healthy lifestyle habits, stress management, and mental health support.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1001,
                            "end": 1177,
                            "score": 0.5,
                            "text": "It's also important to note that weight loss interventions should be sensitive to the individual's body image and should not promote unhealthy or unrealistic weight loss goals.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3581_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1178,
                            "end": 1244,
                            "score": 0.5,
                            "text": "It's important to focus on healthy habits rather than weight loss.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3978",
            "question": "How does pregabalin compare with alternative antiepileptic drugs (AEDs) as an add\u2010on for adults with drug\u2010resistant focal epilepsy?",
            "gold_answer": "For adults with drug\u2010resistant focal epilepsy taking up to three AEDs, evidence that adding pregabalin to the AED regimen increases the number of people achieving seizure freedom at 16 to 21 weeks' follow\u2010up (on average, 88 vs 149 per 1000 people) is of very low certainty and is insufficient to support such a conclusion. Low\u2010certainty evidence suggests little to no impact on the absolute numbers of people experiencing a 50% or greater reduction in seizures or treatment withdrawal compared with an alternative add\u2010on treatment (lamotrigine, levetiracetam, or gabapentin). Results for adverse events were imprecise. No firm conclusions can be drawn.",
            "gold_answer_terms": "REGIMEN (regimen): pattern of giving treatment",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3978",
            "llm_answer": "Pregabalin has been shown to be effective as an add-on treatment for adults with drug-resistant focal epilepsy, with a similar efficacy profile to other alternative antiepileptic drugs (AEDs) such as levetiracetam, lacosamide, and carbamazepine. However, pregabalin may have a better tolerability profile compared to some other AEDs, with a lower risk of certain side effects such as cognitive impairment and weight gain. Additionally, pregabalin has been shown to have a more rapid onset of action compared to some other AEDs, which may be beneficial for patients who have tried multiple other treatments without success. Ultimately, the choice between pregabalin and other AEDs will depend on individual patient factors and the patient's response to previous treatments.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> How does pregabalin compare with alternative antiepileptic drugs (AEDs) as an add\u2010on for adults with drug\u2010resistant focal epilepsy?[/INST]",
            "topic1": [
                "child health",
                "neurology"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Tort, Sera; Ciapponi, Agust\u00edn"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 245,
                            "score": 0.5,
                            "text": "Pregabalin has been shown to be effective as an add-on treatment for adults with drug-resistant focal epilepsy, with a similar efficacy profile to other alternative antiepileptic drugs (AEDs) such as levetiracetam, lacosamide, and carbamazepine.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 246,
                            "end": 421,
                            "score": 0.5,
                            "text": "However, pregabalin may have a better tolerability profile compared to some other AEDs, with a lower risk of certain side effects such as cognitive impairment and weight gain.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 422,
                            "end": 622,
                            "score": 0.5,
                            "text": "Additionally, pregabalin has been shown to have a more rapid onset of action compared to some other AEDs, which may be beneficial for patients who have tried multiple other treatments without success.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 623,
                            "end": 772,
                            "score": 0.5,
                            "text": "Ultimately, the choice between pregabalin and other AEDs will depend on individual patient factors and the patient's response to previous treatments.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3978",
            "question": "How does pregabalin compare with alternative antiepileptic drugs (AEDs) as an add\u2010on for adults with drug\u2010resistant focal epilepsy?",
            "gold_answer": "For adults with drug\u2010resistant focal epilepsy taking up to three AEDs, evidence that adding pregabalin to the AED regimen increases the number of people achieving seizure freedom at 16 to 21 weeks' follow\u2010up (on average, 88 vs 149 per 1000 people) is of very low certainty and is insufficient to support such a conclusion. Low\u2010certainty evidence suggests little to no impact on the absolute numbers of people experiencing a 50% or greater reduction in seizures or treatment withdrawal compared with an alternative add\u2010on treatment (lamotrigine, levetiracetam, or gabapentin). Results for adverse events were imprecise. No firm conclusions can be drawn.",
            "gold_answer_terms": "REGIMEN (regimen): pattern of giving treatment",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3978",
            "llm_answer": "Pregabalin has been shown to be effective as an add-on treatment for adults with drug-resistant focal epilepsy, but its effectiveness can vary compared to other alternative antiepileptic drugs (AEDs).\nA systematic review and meta-analysis published in the Cochrane Database of Systematic Reviews found that pregabalin was associated with a significant reduction in seizure frequency compared to placebo in patients with drug-resistant focal epilepsy. However, the review also noted that the quality of the evidence was generally low and that further research is needed to determine the long-term efficacy and safety of pregabalin for this indication.\nCompared to other AEDs, pregabalin has some unique advantages and disadvantages. For example, pregabalin has a different mechanisms of action than other AEDs, which may make it a useful alternative for patients who have not responded to other treatments. However, pregabalin has been associated with a higher risk of certain adverse events, such as dizziness, somnolence, and fatigue, compared to some other AEDs.\nUltimately, the choice between pregabalin and other AEDs as an add-on treatment for drug-resistant focal epilepsy should be individualized and based on a patient's specific needs and medical history. It is important to work closely with a healthcare provider to determine the most appropriate treatment plan.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> How does pregabalin compare with alternative antiepileptic drugs (AEDs) as an add\u2010on for adults with drug\u2010resistant focal epilepsy?[/INST]",
            "topic1": [
                "child health",
                "neurology"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Tort, Sera; Ciapponi, Agust\u00edn"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 200,
                            "score": 0.5,
                            "text": "Pregabalin has been shown to be effective as an add-on treatment for adults with drug-resistant focal epilepsy, but its effectiveness can vary compared to other alternative antiepileptic drugs (AEDs).",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 201,
                            "end": 450,
                            "score": 0.5,
                            "text": "A systematic review and meta-analysis published in the Cochrane Database of Systematic Reviews found that pregabalin was associated with a significant reduction in seizure frequency compared to placebo in patients with drug-resistant focal epilepsy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 451,
                            "end": 650,
                            "score": 0.5,
                            "text": "However, the review also noted that the quality of the evidence was generally low and that further research is needed to determine the long-term efficacy and safety of pregabalin for this indication.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 651,
                            "end": 731,
                            "score": 0.5,
                            "text": "Compared to other AEDs, pregabalin has some unique advantages and disadvantages.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 732,
                            "end": 905,
                            "score": 0.5,
                            "text": "For example, pregabalin has a different mechanisms of action than other AEDs, which may make it a useful alternative for patients who have not responded to other treatments.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 906,
                            "end": 1064,
                            "score": 0.5,
                            "text": "However, pregabalin has been associated with a higher risk of certain adverse events, such as dizziness, somnolence, and fatigue, compared to some other AEDs.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1065,
                            "end": 1264,
                            "score": 0.5,
                            "text": "Ultimately, the choice between pregabalin and other AEDs as an add-on treatment for drug-resistant focal epilepsy should be individualized and based on a patient's specific needs and medical history.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3978_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1265,
                            "end": 1373,
                            "score": 0.5,
                            "text": "It is important to work closely with a healthcare provider to determine the most appropriate treatment plan.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3702",
            "question": "For people with esophageal varices due to liver cirrhosis, how do interventions for primary prevention of variceal bleeding compare with no active intervention and with one another?",
            "gold_answer": "Beta blockers and variceal band ligation (VBL) seem to perform better versus other treatment options for people with esophageal varices due to liver cirrhosis in terms of mortality, variceal bleeding, and numbers of adverse events. However, only the network meta\u2010analysis (NMA) for mortality included all nine treatment options; reviewers rated all evidence as low or very low certainty and stated that findings were applicable only to people with medium or large esophageal varices or small varices at high risk of bleeding. Reviewers performed NMAs comparing nine treatment options (beta blocker; VBL; sclerotherapy; nitrates; portocaval shunt; beta blockers plus VBL; sclerotherapy; nitrates; no active intervention) for primary prevention of variceal bleeding for people with esophageal varices due to liver cirrhosis. The Cochrane Review included 66 RCTs, with 7 to 57 RCTs included in individual NMAs. Reviewers rated evidence as low certainty for comparisons suggesting a difference between groups, and as very low certainty for comparisons for which the result was less precise. Reviewers reported absolute values per 1000 people for four treatment options (no active intervention; VBL; sclerotherapy; beta blockers/VBL) compared with beta blockers. Only the NMA for mortality included all nine treatment options. This NMA suggests that beta blockers, VBL, sclerotherapy, nitrates, and beta blockers/nitrates have lower mortality than no active intervention; beta blockers and VBL have lower mortality than beta blockers/sclerotherapy; and beta blockers/sclerotherapy have lower mortality than beta blockers alone. Mortality rate was 212 per 1000 people for beta blockers (all values on average) versus 433 for no active intervention, 223 for VBL, 287 for sclerotherapy, and 235 for beta blockers/VBL. Reviewers performed an NMA including only trials published in 2000 or later that demonstrated sclerotherapy had higher mortality than active treatments more commonly used in current clinical practice (beta blockers; VBL; beta blockers/VBL; beta blockers/nitrates; nitrates). Seven treatment options were compared in the NMA for any variceal bleed (beta blockers/sclerotherapy and portocaval shunt were omitted). This NMA suggests that beta blockers, VBL, sclerotherapy, and beta blockers/VBL may result in fewer variceal bleeds than no active intervention; and beta blockers/VBL may result in fewer variceal bleeds than nitrates. Rate of variceal bleed was 97 per 1000 people with beta blockers versus 262 with no active intervention, 70 with VBL, 98 with sclerotherapy, and 21 with beta blockers/VBL. Five treatment options were compared in the NMA for adverse events based on the number of events rather than the number of participants experiencing an adverse event (beta blockers, beta blockers/VBL, VBL, sclerotherapy, no active treatment). This NMA suggests that VBL, beta blockers, beta blockers/VBL, and no active intervention had fewer adverse events than sclerotherapy; and VBL had fewer adverse events than beta blockers or beta blockers/VBL. Beta blockers may also have fewer adverse events than beta blockers/VBL. NMAs for other outcomes included only three treatment options (other features of decompensation), yielded results for all pairwise comparisons that were too imprecise to suggest the presence of absence of an effect (liver transplantation, symptomatic variceal bleed, number of participants with an adverse event), or both (serious adverse events). Evidence for quality of life was absent.",
            "gold_answer_terms": "VARICES (varices): enlarged veins\nTERM (term): Between 37 and 42 weeks of pregnancy.\nMORTALITY (mortality): death\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nRCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nCLINICAL (clinical): pertaining to medical care\nSYMPTOMATIC (symptomatic): having symptoms",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3702",
            "llm_answer": "Interventions for primary prevention of variceal bleeding in people with esophageal varices due to liver cirrhosis include endoscopic variceal ligation (EVL), endoscopic variceal injection (EVI), and beta-blockers. Compared to no active intervention, these interventions have been shown to significantly reduce the risk of variceal bleeding and improve survival.\nCompared to EVI, EVL has been shown to be more effective in preventing variceal bleeding and improving survival. Beta-blockers have also been shown to be effective in reducing the risk of variceal bleeding, but the evidence is less strong compared to EVL and EVI.\nIt is important to note that the choice of intervention may depend on various factors, such as the patient's overall health status, the size and location of the varices, and the presence of other comorbidities. It is recommended to discuss the best treatment options with a healthcare professional.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For people with esophageal varices due to liver cirrhosis, how do interventions for primary prevention of variceal bleeding compare with no active intervention and with one another?[/INST]",
            "topic1": [
                "gastroenterology hepatology"
            ],
            "topic2": [
                "liver disorder"
            ],
            "year": 2021,
            "author": "Burch, Jane; El\u2010Nakeep, Sarah"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 214,
                            "score": 0.5,
                            "text": "Interventions for primary prevention of variceal bleeding in people with esophageal varices due to liver cirrhosis include endoscopic variceal ligation (EVL), endoscopic variceal injection (EVI), and beta-blockers.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 215,
                            "end": 362,
                            "score": 0.5,
                            "text": "Compared to no active intervention, these interventions have been shown to significantly reduce the risk of variceal bleeding and improve survival.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 363,
                            "end": 475,
                            "score": 0.5,
                            "text": "Compared to EVI, EVL has been shown to be more effective in preventing variceal bleeding and improving survival.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 476,
                            "end": 626,
                            "score": 0.5,
                            "text": "Beta-blockers have also been shown to be effective in reducing the risk of variceal bleeding, but the evidence is less strong compared to EVL and EVI.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 627,
                            "end": 837,
                            "score": 0.5,
                            "text": "It is important to note that the choice of intervention may depend on various factors, such as the patient's overall health status, the size and location of the varices, and the presence of other comorbidities.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt0_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 838,
                            "end": 925,
                            "score": 0.5,
                            "text": "It is recommended to discuss the best treatment options with a healthcare professional.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3702",
            "question": "For people with esophageal varices due to liver cirrhosis, how do interventions for primary prevention of variceal bleeding compare with no active intervention and with one another?",
            "gold_answer": "Beta blockers and variceal band ligation (VBL) seem to perform better versus other treatment options for people with esophageal varices due to liver cirrhosis in terms of mortality, variceal bleeding, and numbers of adverse events. However, only the network meta\u2010analysis (NMA) for mortality included all nine treatment options; reviewers rated all evidence as low or very low certainty and stated that findings were applicable only to people with medium or large esophageal varices or small varices at high risk of bleeding. Reviewers performed NMAs comparing nine treatment options (beta blocker; VBL; sclerotherapy; nitrates; portocaval shunt; beta blockers plus VBL; sclerotherapy; nitrates; no active intervention) for primary prevention of variceal bleeding for people with esophageal varices due to liver cirrhosis. The Cochrane Review included 66 RCTs, with 7 to 57 RCTs included in individual NMAs. Reviewers rated evidence as low certainty for comparisons suggesting a difference between groups, and as very low certainty for comparisons for which the result was less precise. Reviewers reported absolute values per 1000 people for four treatment options (no active intervention; VBL; sclerotherapy; beta blockers/VBL) compared with beta blockers. Only the NMA for mortality included all nine treatment options. This NMA suggests that beta blockers, VBL, sclerotherapy, nitrates, and beta blockers/nitrates have lower mortality than no active intervention; beta blockers and VBL have lower mortality than beta blockers/sclerotherapy; and beta blockers/sclerotherapy have lower mortality than beta blockers alone. Mortality rate was 212 per 1000 people for beta blockers (all values on average) versus 433 for no active intervention, 223 for VBL, 287 for sclerotherapy, and 235 for beta blockers/VBL. Reviewers performed an NMA including only trials published in 2000 or later that demonstrated sclerotherapy had higher mortality than active treatments more commonly used in current clinical practice (beta blockers; VBL; beta blockers/VBL; beta blockers/nitrates; nitrates). Seven treatment options were compared in the NMA for any variceal bleed (beta blockers/sclerotherapy and portocaval shunt were omitted). This NMA suggests that beta blockers, VBL, sclerotherapy, and beta blockers/VBL may result in fewer variceal bleeds than no active intervention; and beta blockers/VBL may result in fewer variceal bleeds than nitrates. Rate of variceal bleed was 97 per 1000 people with beta blockers versus 262 with no active intervention, 70 with VBL, 98 with sclerotherapy, and 21 with beta blockers/VBL. Five treatment options were compared in the NMA for adverse events based on the number of events rather than the number of participants experiencing an adverse event (beta blockers, beta blockers/VBL, VBL, sclerotherapy, no active treatment). This NMA suggests that VBL, beta blockers, beta blockers/VBL, and no active intervention had fewer adverse events than sclerotherapy; and VBL had fewer adverse events than beta blockers or beta blockers/VBL. Beta blockers may also have fewer adverse events than beta blockers/VBL. NMAs for other outcomes included only three treatment options (other features of decompensation), yielded results for all pairwise comparisons that were too imprecise to suggest the presence of absence of an effect (liver transplantation, symptomatic variceal bleed, number of participants with an adverse event), or both (serious adverse events). Evidence for quality of life was absent.",
            "gold_answer_terms": "VARICES (varices): enlarged veins\nTERM (term): Between 37 and 42 weeks of pregnancy.\nMORTALITY (mortality): death\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nRCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nCLINICAL (clinical): pertaining to medical care\nSYMPTOMATIC (symptomatic): having symptoms",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3702",
            "llm_answer": "Interventions for primary prevention of variceal bleeding in people with esophageal varices due to liver cirrhosis include endoscopic variceal ligation (EVL), endoscopic variceal injection (EVI), and propranolol.\nCompared to no active intervention, these interventions have been shown to significantly reduce the risk of variceal bleeding. A systematic review and meta-analysis published in the Cochrane Database of Systematic Reviews found that EVL and EVI were both effective in reducing the risk of variceal bleeding, with a pooled risk ratio of 0.37 (95% CI: 0.27-0.50) for EVL and 0.43 (95% CI: 0.29-0.63) for EVI, compared to no intervention.\nIn terms of comparing the different interventions with each other, a meta-analysis published in the Journal of Hepatology found that EVL and EVI had similar efficacy in preventing variceal bleeding, with a pooled risk ratio of 1.03 (95% CI: 0.76-1.40) for EVL versus EVI. However, EVL was associated with a higher risk of adverse events, such as chest pain and respiratory symptoms, compared to EVI.\nIt is important to note that these interventions may have different effects in different populations and settings, and the choice of intervention should be individualized based on patient factors and local resources. Additionally, these interventions are not mutually exclusive, and a combination of endoscopic and pharmacological therapies may be used in some cases.\nIn summary, endoscopic variceal ligation, endoscopic variceal injection, and propranolol are all effective interventions for primary prevention of variceal bleeding in people with esophageal varices due to liver cirrhosis. The choice of intervention should be individualized based on patient factors and local resources, and a combination of endoscopic and pharmacological therapies may be used in some cases.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For people with esophageal varices due to liver cirrhosis, how do interventions for primary prevention of variceal bleeding compare with no active intervention and with one another?[/INST]",
            "topic1": [
                "gastroenterology hepatology"
            ],
            "topic2": [
                "liver disorder"
            ],
            "year": 2021,
            "author": "Burch, Jane; El\u2010Nakeep, Sarah"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 212,
                            "score": 0.5,
                            "text": "Interventions for primary prevention of variceal bleeding in people with esophageal varices due to liver cirrhosis include endoscopic variceal ligation (EVL), endoscopic variceal injection (EVI), and propranolol.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 213,
                            "end": 339,
                            "score": 0.5,
                            "text": "Compared to no active intervention, these interventions have been shown to significantly reduce the risk of variceal bleeding.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 340,
                            "end": 648,
                            "score": 0.5,
                            "text": "A systematic review and meta-analysis published in the Cochrane Database of Systematic Reviews found that EVL and EVI were both effective in reducing the risk of variceal bleeding, with a pooled risk ratio of 0.37 (95% CI: 0.27-0.50) for EVL and 0.43 (95% CI: 0.29-0.63) for EVI, compared to no intervention.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 649,
                            "end": 920,
                            "score": 0.5,
                            "text": "In terms of comparing the different interventions with each other, a meta-analysis published in the Journal of Hepatology found that EVL and EVI had similar efficacy in preventing variceal bleeding, with a pooled risk ratio of 1.03 (95% CI: 0.76-1.40) for EVL versus EVI.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 921,
                            "end": 1048,
                            "score": 0.5,
                            "text": "However, EVL was associated with a higher risk of adverse events, such as chest pain and respiratory symptoms, compared to EVI.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1049,
                            "end": 1265,
                            "score": 0.5,
                            "text": "It is important to note that these interventions may have different effects in different populations and settings, and the choice of intervention should be individualized based on patient factors and local resources.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1266,
                            "end": 1416,
                            "score": 0.5,
                            "text": "Additionally, these interventions are not mutually exclusive, and a combination of endoscopic and pharmacological therapies may be used in some cases.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1417,
                            "end": 1639,
                            "score": 0.5,
                            "text": "In summary, endoscopic variceal ligation, endoscopic variceal injection, and propranolol are all effective interventions for primary prevention of variceal bleeding in people with esophageal varices due to liver cirrhosis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3702_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1640,
                            "end": 1826,
                            "score": 0.5,
                            "text": "The choice of intervention should be individualized based on patient factors and local resources, and a combination of endoscopic and pharmacological therapies may be used in some cases.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3352",
            "question": "How does motor imagery compare with other therapies for gait rehabilitation in adults after stroke?",
            "gold_answer": "Reviewers identified six studies that assessed motor imagery compared with other therapies for gait rehabilitation in adults after stroke. Very low\u2010certainty evidence suggests that motor imagery may moderately improve walking speed. Data on the impact of motor imagery on motor function, functional mobility, adverse events, and walking endurance are unclear due to internal validity issues of the included studies.",
            "gold_answer_terms": "ASSESS (assess): to learn about, measure, evaluate, look at\nMOBILITY (mobility): ease of movement\nINTERNAL (internal): within the body",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3352",
            "llm_answer": "Motor imagery, which involves mentally simulating movements without actually performing them, has been found to be an effective tool for gait rehabilitation in adults after stroke. Research has shown that motor imagery can improve gait speed, balance, and functional ability in individuals with stroke, and may be as effective as other forms of therapy, such as physical practice or visual feedback, in improving gait outcomes. Additionally, motor imagery has the advantage of being able to be performed in a variety of settings, including in the home, making it a convenient and accessible option for individuals who may have difficulty accessing traditional therapy sessions. However, it is important to note that motor imagery is not a replacement for physical practice and should be used in conjunction with other forms of therapy for optimal gait rehabilitation outcomes.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> How does motor imagery compare with other therapies for gait rehabilitation in adults after stroke?[/INST]",
            "topic1": [
                "heart circulation",
                "neurology"
            ],
            "topic2": [
                "stroke"
            ],
            "year": 2021,
            "author": "Jackson, Christopher"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 180,
                            "score": 0.5,
                            "text": "Motor imagery, which involves mentally simulating movements without actually performing them, has been found to be an effective tool for gait rehabilitation in adults after stroke.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 181,
                            "end": 427,
                            "score": 0.5,
                            "text": "Research has shown that motor imagery can improve gait speed, balance, and functional ability in individuals with stroke, and may be as effective as other forms of therapy, such as physical practice or visual feedback, in improving gait outcomes.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 428,
                            "end": 677,
                            "score": 0.5,
                            "text": "Additionally, motor imagery has the advantage of being able to be performed in a variety of settings, including in the home, making it a convenient and accessible option for individuals who may have difficulty accessing traditional therapy sessions.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 678,
                            "end": 876,
                            "score": 0.5,
                            "text": "However, it is important to note that motor imagery is not a replacement for physical practice and should be used in conjunction with other forms of therapy for optimal gait rehabilitation outcomes.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3352",
            "question": "How does motor imagery compare with other therapies for gait rehabilitation in adults after stroke?",
            "gold_answer": "Reviewers identified six studies that assessed motor imagery compared with other therapies for gait rehabilitation in adults after stroke. Very low\u2010certainty evidence suggests that motor imagery may moderately improve walking speed. Data on the impact of motor imagery on motor function, functional mobility, adverse events, and walking endurance are unclear due to internal validity issues of the included studies.",
            "gold_answer_terms": "ASSESS (assess): to learn about, measure, evaluate, look at\nMOBILITY (mobility): ease of movement\nINTERNAL (internal): within the body",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3352",
            "llm_answer": "Motor imagery is a promising tool for gait rehabilitation in adults after stroke, and it has been found to be effective in improving gait function and reducing gait-related disabilities. Compared to other therapies, motor imagery has several advantages.\nFirstly, motor imagery can be performed in a non-weight-bearing environment, which makes it particularly useful for individuals who are unable to bear weight on their affected limbs due to weakness or spasticity. This allows patients to practice and reinforce gait patterns without putting excessive strain on their joints or muscles.\nSecondly, motor imagery can be tailored to the individual's specific needs and abilities, allowing for a more personalized approach to rehabilitation. By focusing on the specific muscles and movements involved in gait, patients can target their rehabilitation efforts more effectively.\nThirdly, motor imagery can be combined with other therapies, such as physical therapy, occupational therapy, and orthotics, to enhance their effectiveness. For example, patients can practice motor imagery exercises at home in between physical therapy sessions, which can help to reinforce the gains made during therapy and promote faster recovery.\nFinally, motor imagery is a low-cost and non-invasive intervention, which makes it an attractive option for patients who may not have access to other forms of rehabilitation or who may be unable to afford more expensive treatments.\nOverall, while motor imagery is not a replacement for other therapies, it can be a useful adjunct to traditional rehabilitation methods and may offer several advantages for gait rehabilitation in adults after stroke.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> How does motor imagery compare with other therapies for gait rehabilitation in adults after stroke?[/INST]",
            "topic1": [
                "heart circulation",
                "neurology"
            ],
            "topic2": [
                "stroke"
            ],
            "year": 2021,
            "author": "Jackson, Christopher"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 186,
                            "score": 0.5,
                            "text": "Motor imagery is a promising tool for gait rehabilitation in adults after stroke, and it has been found to be effective in improving gait function and reducing gait-related disabilities.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 187,
                            "end": 253,
                            "score": 0.5,
                            "text": "Compared to other therapies, motor imagery has several advantages.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 254,
                            "end": 466,
                            "score": 0.5,
                            "text": "Firstly, motor imagery can be performed in a non-weight-bearing environment, which makes it particularly useful for individuals who are unable to bear weight on their affected limbs due to weakness or spasticity.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 467,
                            "end": 588,
                            "score": 0.5,
                            "text": "This allows patients to practice and reinforce gait patterns without putting excessive strain on their joints or muscles.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 589,
                            "end": 739,
                            "score": 0.5,
                            "text": "Secondly, motor imagery can be tailored to the individual's specific needs and abilities, allowing for a more personalized approach to rehabilitation.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 740,
                            "end": 874,
                            "score": 0.5,
                            "text": "By focusing on the specific muscles and movements involved in gait, patients can target their rehabilitation efforts more effectively.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 875,
                            "end": 1030,
                            "score": 0.5,
                            "text": "Thirdly, motor imagery can be combined with other therapies, such as physical therapy, occupational therapy, and orthotics, to enhance their effectiveness.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1031,
                            "end": 1222,
                            "score": 0.5,
                            "text": "For example, patients can practice motor imagery exercises at home in between physical therapy sessions, which can help to reinforce the gains made during therapy and promote faster recovery.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1223,
                            "end": 1454,
                            "score": 0.5,
                            "text": "Finally, motor imagery is a low-cost and non-invasive intervention, which makes it an attractive option for patients who may not have access to other forms of rehabilitation or who may be unable to afford more expensive treatments.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3352_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1455,
                            "end": 1671,
                            "score": 0.5,
                            "text": "Overall, while motor imagery is not a replacement for other therapies, it can be a useful adjunct to traditional rehabilitation methods and may offer several advantages for gait rehabilitation in adults after stroke.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4182",
            "question": "Do preschool children diagnosed with autism spectrum disorder (ASD) continue to meet diagnostic criteria at follow\u2010up?",
            "gold_answer": "Reviewers conducted a prognosis Cochrane Review to answer this clinical question. They identified low\u2010certainty evidence suggesting that 92% of preschool children diagnosed with ASD at a mean age three years retain their diagnosis after a mean follow\u2010up of three years. Change in social communication or restricted and repetitive behavior and interests could not be evaluated over time because none of the included studies provided separate data at baseline and follow\u2010up.",
            "gold_answer_terms": "PROGNOSIS (prognosis): outlook, probable outcomes\nCLINICAL (clinical): pertaining to medical care\nDIAGNOSIS (diagnosis): The way a medical professional recognises a condition or disease.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4182",
            "llm_answer": "Yes, research suggests that the majority of preschool children diagnosed with autism spectrum disorder (ASD) continue to meet diagnostic criteria at follow-up, although the severity of symptoms may vary over time. A study published in the Journal of the American Academy of Child and Adolescent Psychiatry found that 78% of children diagnosed with ASD at age 2-3 still met criteria for the disorder at age 5-6. However, it's important to note that some children may experience improvements in symptoms over time, and a small percentage may lose their diagnosis.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> Do preschool children diagnosed with autism spectrum disorder (ASD) continue to meet diagnostic criteria at follow\u2010up?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2023,
            "author": "Ciapponi, Agust\u00edn; Tort, Sera"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4182_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4182_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 213,
                            "score": 0.5,
                            "text": "Yes, research suggests that the majority of preschool children diagnosed with autism spectrum disorder (ASD) continue to meet diagnostic criteria at follow-up, although the severity of symptoms may vary over time.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4182_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 214,
                            "end": 410,
                            "score": 0.5,
                            "text": "A study published in the Journal of the American Academy of Child and Adolescent Psychiatry found that 78% of children diagnosed with ASD at age 2-3 still met criteria for the disorder at age 5-6.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4182_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 411,
                            "end": 561,
                            "score": 0.5,
                            "text": "However, it's important to note that some children may experience improvements in symptoms over time, and a small percentage may lose their diagnosis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4182",
            "question": "Do preschool children diagnosed with autism spectrum disorder (ASD) continue to meet diagnostic criteria at follow\u2010up?",
            "gold_answer": "Reviewers conducted a prognosis Cochrane Review to answer this clinical question. They identified low\u2010certainty evidence suggesting that 92% of preschool children diagnosed with ASD at a mean age three years retain their diagnosis after a mean follow\u2010up of three years. Change in social communication or restricted and repetitive behavior and interests could not be evaluated over time because none of the included studies provided separate data at baseline and follow\u2010up.",
            "gold_answer_terms": "PROGNOSIS (prognosis): outlook, probable outcomes\nCLINICAL (clinical): pertaining to medical care\nDIAGNOSIS (diagnosis): The way a medical professional recognises a condition or disease.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4182",
            "llm_answer": "Yes, many preschool children diagnosed with autism spectrum disorder (ASD) continue to meet diagnostic criteria at follow-up. Studies have shown that the majority of children diagnosed with ASD in early childhood continue to meet the diagnostic criteria for the disorder as they grow older. However, it's important to note that the severity of symptoms and the child's level of functioning can vary over time, and some children may experience improvements in certain areas while still meeting the diagnostic criteria for ASD. It's also important to note that ASD is a spectrum disorder, and each child's experience and progression can be unique.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> Do preschool children diagnosed with autism spectrum disorder (ASD) continue to meet diagnostic criteria at follow\u2010up?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2023,
            "author": "Ciapponi, Agust\u00edn; Tort, Sera"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4182_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4182_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 125,
                            "score": 0.5,
                            "text": "Yes, many preschool children diagnosed with autism spectrum disorder (ASD) continue to meet diagnostic criteria at follow-up.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4182_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 126,
                            "end": 290,
                            "score": 0.5,
                            "text": "Studies have shown that the majority of children diagnosed with ASD in early childhood continue to meet the diagnostic criteria for the disorder as they grow older.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4182_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 291,
                            "end": 525,
                            "score": 0.5,
                            "text": "However, it's important to note that the severity of symptoms and the child's level of functioning can vary over time, and some children may experience improvements in certain areas while still meeting the diagnostic criteria for ASD.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4182_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 526,
                            "end": 645,
                            "score": 0.5,
                            "text": "It's also important to note that ASD is a spectrum disorder, and each child's experience and progression can be unique.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3647",
            "question": "For people with pulmonary arterial hypertension, what are the effects of endothelin receptor antagonists (ERAs)?",
            "gold_answer": "Moderate\u2010certainty evidence shows that, compared with placebo, ERAs probably increase six\u2010minute walking distance (by 25 m; all results on average), increase the number of people with improved functional class (199 vs 150 per 1000 people), reduce the proportion of people with deteriorated functional class (44 vs 97 per 1000 people), and reduce mean pulmonary arterial pressure (by 4.65 mmHg) and pulmonary vascular resistance (by 236.24 dyne/s/cm 5 ), but ERAs probably also increase risk of hepatic toxicity (81 vs 45 per 1000 people). Low\u2010certainty evidence suggests ERAs may reduce Borg dyspnea index scores (by 0.43 points) and mortality (39 vs 50 per 1000 people). A report published in 2020 by the FDA states that ambrisentan, bosentan, and sitaxsentan may cause liver damage; sitaxsentan was withdrawn from the market ( EMA press release ).",
            "gold_answer_terms": "PLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nPULMONARY (pulmonary): pertaining to the lungs\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nTOXICITY (toxicity): side effects or undesirable effects of a drug or treatment\nMORTALITY (mortality): death",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3647",
            "llm_answer": "Endothelin receptor antagonists (ERAs) have been shown to improve exercise capacity, symptoms, and survival in people with pulmonary arterial hypertension (PAH). ERAs work by blocking the action of endothelin-1, a potent vasoconstrictor that is overproduced in PAH. By blocking the effects of endothelin-1, ERAs can help to relax the blood vessels in the lungs and improve blood flow, which can lead to increased exercise capacity and reduced symptoms such as shortness of breath. Additionally, ERAs have been shown to slow the progression of PAH and improve survival rates in people with the disease. Common ERAs used to treat PAH include bosentan, ambrisentan, and macitentan.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For people with pulmonary arterial hypertension, what are the effects of endothelin receptor antagonists (ERAs)?[/INST]",
            "topic1": [
                "child health",
                "lungs airways"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Jr, William Cayley"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 161,
                            "score": 0.5,
                            "text": "Endothelin receptor antagonists (ERAs) have been shown to improve exercise capacity, symptoms, and survival in people with pulmonary arterial hypertension (PAH).",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 162,
                            "end": 265,
                            "score": 0.5,
                            "text": "ERAs work by blocking the action of endothelin-1, a potent vasoconstrictor that is overproduced in PAH.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 266,
                            "end": 480,
                            "score": 0.5,
                            "text": "By blocking the effects of endothelin-1, ERAs can help to relax the blood vessels in the lungs and improve blood flow, which can lead to increased exercise capacity and reduced symptoms such as shortness of breath.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 481,
                            "end": 601,
                            "score": 0.5,
                            "text": "Additionally, ERAs have been shown to slow the progression of PAH and improve survival rates in people with the disease.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 602,
                            "end": 678,
                            "score": 0.5,
                            "text": "Common ERAs used to treat PAH include bosentan, ambrisentan, and macitentan.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3647",
            "question": "For people with pulmonary arterial hypertension, what are the effects of endothelin receptor antagonists (ERAs)?",
            "gold_answer": "Moderate\u2010certainty evidence shows that, compared with placebo, ERAs probably increase six\u2010minute walking distance (by 25 m; all results on average), increase the number of people with improved functional class (199 vs 150 per 1000 people), reduce the proportion of people with deteriorated functional class (44 vs 97 per 1000 people), and reduce mean pulmonary arterial pressure (by 4.65 mmHg) and pulmonary vascular resistance (by 236.24 dyne/s/cm 5 ), but ERAs probably also increase risk of hepatic toxicity (81 vs 45 per 1000 people). Low\u2010certainty evidence suggests ERAs may reduce Borg dyspnea index scores (by 0.43 points) and mortality (39 vs 50 per 1000 people). A report published in 2020 by the FDA states that ambrisentan, bosentan, and sitaxsentan may cause liver damage; sitaxsentan was withdrawn from the market ( EMA press release ).",
            "gold_answer_terms": "PLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nPULMONARY (pulmonary): pertaining to the lungs\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nTOXICITY (toxicity): side effects or undesirable effects of a drug or treatment\nMORTALITY (mortality): death",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3647",
            "llm_answer": "Endothelin receptor antagonists (ERAs) are a class of medications that are used to treat pulmonary arterial hypertension (PAH). The effects of ERAs on PAH include:\n1. Relaxation of pulmonary arteries: ERAs work by blocking the action of endothelin-1, a hormone that causes the contraction of pulmonary arteries. By blocking the action of endothelin-1, ERAs relax the pulmonary arteries, which can help to reduce the blood pressure in the lungs and improve blood flow.\n2. Improved exercise capacity: By relaxing the pulmonary arteries, ERAs can improve exercise capacity in people with PAH. This means that people with PAH may be able to perform physical activities with less shortness of breath and fatigue.\n3. Reduced risk of hospitalization: Studies have shown that ERAs can reduce the risk of hospitalization for people with PAH.\n4. Improved survival: Some studies have suggested that ERAs may improve survival rates for people with PAH.\nIt's important to note that ERAs can have side effects, such as headache, dizziness, and nausea. It's important to discuss the potential benefits and risks of ERAs with a healthcare provider to determine if they are appropriate for an individual's specific condition. Additionally, ERAs are not a cure for PAH, and they may not be effective for everyone with the condition.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For people with pulmonary arterial hypertension, what are the effects of endothelin receptor antagonists (ERAs)?[/INST]",
            "topic1": [
                "child health",
                "lungs airways"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Jr, William Cayley"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 127,
                            "score": 0.5,
                            "text": "Endothelin receptor antagonists (ERAs) are a class of medications that are used to treat pulmonary arterial hypertension (PAH).",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 128,
                            "end": 163,
                            "score": 0.5,
                            "text": "The effects of ERAs on PAH include:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 167,
                            "end": 311,
                            "score": 0.5,
                            "text": "Relaxation of pulmonary arteries: ERAs work by blocking the action of endothelin-1, a hormone that causes the contraction of pulmonary arteries.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 312,
                            "end": 467,
                            "score": 0.5,
                            "text": "By blocking the action of endothelin-1, ERAs relax the pulmonary arteries, which can help to reduce the blood pressure in the lungs and improve blood flow.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 471,
                            "end": 589,
                            "score": 0.5,
                            "text": "Improved exercise capacity: By relaxing the pulmonary arteries, ERAs can improve exercise capacity in people with PAH.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 590,
                            "end": 707,
                            "score": 0.5,
                            "text": "This means that people with PAH may be able to perform physical activities with less shortness of breath and fatigue.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 711,
                            "end": 832,
                            "score": 0.5,
                            "text": "Reduced risk of hospitalization: Studies have shown that ERAs can reduce the risk of hospitalization for people with PAH.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 836,
                            "end": 940,
                            "score": 0.5,
                            "text": "Improved survival: Some studies have suggested that ERAs may improve survival rates for people with PAH.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 941,
                            "end": 1037,
                            "score": 0.5,
                            "text": "It's important to note that ERAs can have side effects, such as headache, dizziness, and nausea.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1038,
                            "end": 1208,
                            "score": 0.5,
                            "text": "It's important to discuss the potential benefits and risks of ERAs with a healthcare provider to determine if they are appropriate for an individual's specific condition.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3647_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1209,
                            "end": 1314,
                            "score": 0.5,
                            "text": "Additionally, ERAs are not a cure for PAH, and they may not be effective for everyone with the condition.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3217",
            "question": "What is the accuracy of the rapid diagnostic test based on the antigen F1 (F1RDT) for the diagnosis of plague?",
            "gold_answer": "Reviewers identified only very low\u2010certainty evidence suggesting that rapid diagnostic tests for plague based on the antigen F1 and a detection threshold of 0.5 ng/mL have overall sensitivity of 100% and specificity of 70%. Based on these estimates, cases of plague missed are likely to be rare; however, reviewers reported that, on average, for every 1000 people tested, the numbers of people who may be wrongly diagnosed as having plague could be 300 at a prevalence of 0.1%, 288 at a prevalence of 4%, and 240 at a prevalence of 20%.",
            "gold_answer_terms": "TESTES (testes): male sex glands\nANTIGEN (antigen): A substance in the blood that helps trigger the immune system to develop antibodies. See blood group.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3217",
            "llm_answer": "The accuracy of the rapid diagnostic test based on the antigen F1 (F1RDT) for the diagnosis of plague is variable and depends on various factors, such as the specific test kit used and the patient population being tested.\nSensitivity of F1RDT ranges from 60-90% in different studies, with some studies reporting lower sensitivity in patients with early-stage plague. Specificity is generally high, ranging from 90-100%. However, false negatives can occur in the early stages of infection, and false positives can occur in patients with other bacterial infections or autoimmune disorders.\nTherefore, while F1RDT can be a useful tool for rapid diagnosis of plague, especially in resource-limited settings, it should be used in conjunction with other diagnostic tests and clinical evaluation to increase accuracy.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> What is the accuracy of the rapid diagnostic test based on the antigen F1 (F1RDT) for the diagnosis of plague?[/INST]",
            "topic1": [
                "infectious disease"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Bhat, Smitha"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 221,
                            "score": 0.5,
                            "text": "The accuracy of the rapid diagnostic test based on the antigen F1 (F1RDT) for the diagnosis of plague is variable and depends on various factors, such as the specific test kit used and the patient population being tested.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 222,
                            "end": 366,
                            "score": 0.5,
                            "text": "Sensitivity of F1RDT ranges from 60-90% in different studies, with some studies reporting lower sensitivity in patients with early-stage plague.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 367,
                            "end": 419,
                            "score": 0.5,
                            "text": "Specificity is generally high, ranging from 90-100%.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 420,
                            "end": 587,
                            "score": 0.5,
                            "text": "However, false negatives can occur in the early stages of infection, and false positives can occur in patients with other bacterial infections or autoimmune disorders.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 588,
                            "end": 810,
                            "score": 0.5,
                            "text": "Therefore, while F1RDT can be a useful tool for rapid diagnosis of plague, especially in resource-limited settings, it should be used in conjunction with other diagnostic tests and clinical evaluation to increase accuracy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3217",
            "question": "What is the accuracy of the rapid diagnostic test based on the antigen F1 (F1RDT) for the diagnosis of plague?",
            "gold_answer": "Reviewers identified only very low\u2010certainty evidence suggesting that rapid diagnostic tests for plague based on the antigen F1 and a detection threshold of 0.5 ng/mL have overall sensitivity of 100% and specificity of 70%. Based on these estimates, cases of plague missed are likely to be rare; however, reviewers reported that, on average, for every 1000 people tested, the numbers of people who may be wrongly diagnosed as having plague could be 300 at a prevalence of 0.1%, 288 at a prevalence of 4%, and 240 at a prevalence of 20%.",
            "gold_answer_terms": "TESTES (testes): male sex glands\nANTIGEN (antigen): A substance in the blood that helps trigger the immune system to develop antibodies. See blood group.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3217",
            "llm_answer": "The accuracy of the rapid diagnostic test based on the antigen F1 (F1RDT) for the diagnosis of plague is variable and depends on several factors, such as the specific test kit used, the quality of the sample, and the level of antigen expression in the patient's blood.\nSensitivity, or the proportion of true positive cases, of F1RDT for plague has been reported to range from 60-90% in different studies, with some studies showing higher sensitivity in patients with severe plague. Specificity, or the proportion of true negative cases, has been reported to range from 80-100%. However, it's important to note that the performance of F1RDT may be affected by the presence of antibodies in the patient's blood, which can result in false positive results.\nIt's important to use F1RDT in combination with other diagnostic tests, such as PCR or culture, and clinical evaluation to increase the accuracy of plague diagnosis. Additionally, it's important to note that F1RDT is not recommended for screening purposes, but rather for confirmation of plague in patients with suspected cases.\nIt's important to consult a healthcare professional for proper interpretation and use of F1RDT results, as well as for guidance on appropriate treatment and management of plague.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> What is the accuracy of the rapid diagnostic test based on the antigen F1 (F1RDT) for the diagnosis of plague?[/INST]",
            "topic1": [
                "infectious disease"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Bhat, Smitha"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 268,
                            "score": 0.5,
                            "text": "The accuracy of the rapid diagnostic test based on the antigen F1 (F1RDT) for the diagnosis of plague is variable and depends on several factors, such as the specific test kit used, the quality of the sample, and the level of antigen expression in the patient's blood.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 269,
                            "end": 481,
                            "score": 0.5,
                            "text": "Sensitivity, or the proportion of true positive cases, of F1RDT for plague has been reported to range from 60-90% in different studies, with some studies showing higher sensitivity in patients with severe plague.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 482,
                            "end": 577,
                            "score": 0.5,
                            "text": "Specificity, or the proportion of true negative cases, has been reported to range from 80-100%.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 578,
                            "end": 753,
                            "score": 0.5,
                            "text": "However, it's important to note that the performance of F1RDT may be affected by the presence of antibodies in the patient's blood, which can result in false positive results.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 754,
                            "end": 919,
                            "score": 0.5,
                            "text": "It's important to use F1RDT in combination with other diagnostic tests, such as PCR or culture, and clinical evaluation to increase the accuracy of plague diagnosis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 920,
                            "end": 1082,
                            "score": 0.5,
                            "text": "Additionally, it's important to note that F1RDT is not recommended for screening purposes, but rather for confirmation of plague in patients with suspected cases.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3217_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1083,
                            "end": 1261,
                            "score": 0.5,
                            "text": "It's important to consult a healthcare professional for proper interpretation and use of F1RDT results, as well as for guidance on appropriate treatment and management of plague.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3885",
            "question": "For adults in low\u2010 and middle\u2010income countries living with common mental disorders, perinatal depression, or post\u2010traumatic stress disorder, what are the effects of primary health care worker (PHCW)\u2010led interventions?",
            "gold_answer": "In 2019, reviewers identified trials evaluating PHCW\u2010led psychological interventions for adults residing in low\u2010 and middle\u2010income countries living with common mental disorders (13 RCTs), perinatal depression (2 RCTs), or post\u2010traumatic stress disorder (PTSD), or with common mental disorders in humanitarian settings (3 RCTs). Outcomes assessed were recovery, prevalence, symptoms, quality of life, and functional impairment in the short, intermediate, and long term. Moderate\u2010certainty evidence shows that PHCW\u2010led interventions probably improve short\u2010term anxiety symptoms for people with PTSD, long\u2010term symptoms for women with perinatal depression, and intermediate functional impairment scores for people with common mental disorders. Improvements were small to moderate. Reviewers identified only very low\u2010 to low\u2010certainty evidence for all other outcomes across the three populations, making it difficult to draw firm conclusions.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nASSESS (assess): to learn about, measure, evaluate, look at\nSYMPTOM (symptom): A specific medical sign of a condition, illness or disease.\nTERM (term): Between 37 and 42 weeks of pregnancy.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3885",
            "llm_answer": "PHCW-led interventions have been shown to be effective in improving mental health outcomes for adults in low- and middle-income countries living with common mental disorders, perinatal depression, or post-traumatic stress disorder. These interventions typically involve training PHCWs to recognize and treat mental health conditions, providing psychotherapy and medication, and referring patients to specialized care when necessary. Studies have shown that PHCW-led interventions can lead to significant improvements in symptom reduction, recovery rates, and quality of life for patients with mental health conditions. Additionally, these interventions have been found to be cost-effective and feasible to implement in resource-constrained settings.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For adults in low\u2010 and middle\u2010income countries living with common mental disorders, perinatal depression, or post\u2010traumatic stress disorder, what are the effects of primary health care worker (PHCW)\u2010led interventions?[/INST]",
            "topic1": [
                "child health",
                "mental health"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Ray, Sujoy"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3885_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3885_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 231,
                            "score": 0.5,
                            "text": "PHCW-led interventions have been shown to be effective in improving mental health outcomes for adults in low- and middle-income countries living with common mental disorders, perinatal depression, or post-traumatic stress disorder.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3885_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 232,
                            "end": 432,
                            "score": 0.5,
                            "text": "These interventions typically involve training PHCWs to recognize and treat mental health conditions, providing psychotherapy and medication, and referring patients to specialized care when necessary.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3885_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 433,
                            "end": 618,
                            "score": 0.5,
                            "text": "Studies have shown that PHCW-led interventions can lead to significant improvements in symptom reduction, recovery rates, and quality of life for patients with mental health conditions.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3885_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 619,
                            "end": 749,
                            "score": 0.5,
                            "text": "Additionally, these interventions have been found to be cost-effective and feasible to implement in resource-constrained settings.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3885",
            "question": "For adults in low\u2010 and middle\u2010income countries living with common mental disorders, perinatal depression, or post\u2010traumatic stress disorder, what are the effects of primary health care worker (PHCW)\u2010led interventions?",
            "gold_answer": "In 2019, reviewers identified trials evaluating PHCW\u2010led psychological interventions for adults residing in low\u2010 and middle\u2010income countries living with common mental disorders (13 RCTs), perinatal depression (2 RCTs), or post\u2010traumatic stress disorder (PTSD), or with common mental disorders in humanitarian settings (3 RCTs). Outcomes assessed were recovery, prevalence, symptoms, quality of life, and functional impairment in the short, intermediate, and long term. Moderate\u2010certainty evidence shows that PHCW\u2010led interventions probably improve short\u2010term anxiety symptoms for people with PTSD, long\u2010term symptoms for women with perinatal depression, and intermediate functional impairment scores for people with common mental disorders. Improvements were small to moderate. Reviewers identified only very low\u2010 to low\u2010certainty evidence for all other outcomes across the three populations, making it difficult to draw firm conclusions.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nASSESS (assess): to learn about, measure, evaluate, look at\nSYMPTOM (symptom): A specific medical sign of a condition, illness or disease.\nTERM (term): Between 37 and 42 weeks of pregnancy.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3885",
            "llm_answer": "According to research, primary health care worker (PHCW) - led interventions have been shown to be effective in improving the mental health outcomes of adults in low- and middle-income countries living with common mental disorders, perinatal depression, or post-traumatic stress disorder. These interventions typically involve training PHCWs to recognize and treat mental health conditions, providing psychotherapy and counseling, and referring patients to specialized mental health services when necessary. Studies have shown that PHCW-led interventions can lead to significant improvements in symptoms of depression, anxiety, and post-traumatic stress, as well as improved quality of life and social functioning. Additionally, these interventions have been found to be cost-effective and feasible to implement in resource-constrained settings. It is important to note that while PHCW-led interventions can be effective, they should be part of a comprehensive mental health care system that includes specialized mental health services and supports.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For adults in low\u2010 and middle\u2010income countries living with common mental disorders, perinatal depression, or post\u2010traumatic stress disorder, what are the effects of primary health care worker (PHCW)\u2010led interventions?[/INST]",
            "topic1": [
                "child health",
                "mental health"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Ray, Sujoy"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3885_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3885_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 288,
                            "score": 0.5,
                            "text": "According to research, primary health care worker (PHCW) - led interventions have been shown to be effective in improving the mental health outcomes of adults in low- and middle-income countries living with common mental disorders, perinatal depression, or post-traumatic stress disorder.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3885_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 289,
                            "end": 507,
                            "score": 0.5,
                            "text": "These interventions typically involve training PHCWs to recognize and treat mental health conditions, providing psychotherapy and counseling, and referring patients to specialized mental health services when necessary.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3885_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 508,
                            "end": 714,
                            "score": 0.5,
                            "text": "Studies have shown that PHCW-led interventions can lead to significant improvements in symptoms of depression, anxiety, and post-traumatic stress, as well as improved quality of life and social functioning.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3885_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 715,
                            "end": 845,
                            "score": 0.5,
                            "text": "Additionally, these interventions have been found to be cost-effective and feasible to implement in resource-constrained settings.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3885_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 846,
                            "end": 1049,
                            "score": 0.5,
                            "text": "It is important to note that while PHCW-led interventions can be effective, they should be part of a comprehensive mental health care system that includes specialized mental health services and supports.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4213",
            "question": "For people who have coagulopathic non\u2010surgical bleeding and who undergo cardiac surgery, how does prothrombin complex concentrate (PCC) compare with fresh frozen plasma (FFP) or recombinant factor VIIa (rFVIIa)?",
            "gold_answer": "For people who have coagulopathic non\u2010surgical bleeding and who undergo cardiac surgery, PCC probably reduces the requirement of red blood cell (RBC) units transfused compared with FFP or rFVIIa. Moderate\u2010certainty evidence from RCTs shows that PCC probably reduces the RBC units transfused (by 0.9 units, all results on average) compared with FFP, with little to no difference between groups in intensive care length of stay and in absolute numbers of thrombotic events or 30\u2010day deaths, but based on underpowered estimations. Low\u2010certainty evidence from non\u2010randomized studies (NRSs) suggests that fewer people required RBC with PCC than with FFP (812 vs 889 per 1000 people); the effect observed among RCTs was similar; however, the range of statistical outcomes encompasses both positive and negative findings, limiting these results. RCTs suggest that there may be little to no difference in postoperative bleeding, absolute number of renal replacement therapy, or adverse events, but again, this was based on underpowered estimations. Moderate\u2010certainty evidence from NRSs shows that PCC probably reduces the RBC units transfused (by 5 units) compared with rFVIIa, but the certainty of evidence for other outcomes was very low, and no study assessed adverse events.",
            "gold_answer_terms": "CARDIAC (cardiac): related to the heart\nCELL (cell): The tiny building blocks which make up the organs and tissues of the body.\nRBC (rbc): red blood cell\nRCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nRENAL (renal): pertaining to the kidneys\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4213",
            "llm_answer": "For people with coagulopathic non-surgical bleeding who undergo cardiac surgery, prothrombin complex concentrate (PCC) is generally considered to be more effective and safer than fresh frozen plasma (FFP) or recombinant factor VIIa (rFVIIa) in promoting hemostasis and reducing bleeding complications. PCC contains a concentrated dose of vitamin K-dependent clotting factors, including prothrombin, which is the primary target of warfarin anticoagulation, and has been shown to rapidly reverse the anticoagulant effect of warfarin. In contrast, FFP contains a mixture of clotting factors and other plasma proteins, and its effectiveness may be limited by the variable composition and quality of the plasma used in its preparation. rFVIIa, on the other hand, is a recombinant form of activated factor VII, which can also promote hemostasis, but its use is associated with a higher risk of thrombotic complications. A meta-analysis of randomized controlled trials has shown that PCC is associated with a lower risk of bleeding and thrombosis compared to FFP or rFVIIa in patients with coagulopathic non-surgical bleeding undergoing cardiac surgery.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For people who have coagulopathic non\u2010surgical bleeding and who undergo cardiac surgery, how does prothrombin complex concentrate (PCC) compare with fresh frozen plasma (FFP) or recombinant factor VIIa (rFVIIa)?[/INST]",
            "topic1": [
                "heart circulation"
            ],
            "topic2": [],
            "year": 2023,
            "author": "Ciapponi, Agust\u00edn; Thapa, Bipin"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 301,
                            "score": 0.5,
                            "text": "For people with coagulopathic non-surgical bleeding who undergo cardiac surgery, prothrombin complex concentrate (PCC) is generally considered to be more effective and safer than fresh frozen plasma (FFP) or recombinant factor VIIa (rFVIIa) in promoting hemostasis and reducing bleeding complications.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 302,
                            "end": 531,
                            "score": 0.5,
                            "text": "PCC contains a concentrated dose of vitamin K-dependent clotting factors, including prothrombin, which is the primary target of warfarin anticoagulation, and has been shown to rapidly reverse the anticoagulant effect of warfarin.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 532,
                            "end": 730,
                            "score": 0.5,
                            "text": "In contrast, FFP contains a mixture of clotting factors and other plasma proteins, and its effectiveness may be limited by the variable composition and quality of the plasma used in its preparation.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 731,
                            "end": 913,
                            "score": 0.5,
                            "text": "rFVIIa, on the other hand, is a recombinant form of activated factor VII, which can also promote hemostasis, but its use is associated with a higher risk of thrombotic complications.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 914,
                            "end": 1146,
                            "score": 0.5,
                            "text": "A meta-analysis of randomized controlled trials has shown that PCC is associated with a lower risk of bleeding and thrombosis compared to FFP or rFVIIa in patients with coagulopathic non-surgical bleeding undergoing cardiac surgery.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4213",
            "question": "For people who have coagulopathic non\u2010surgical bleeding and who undergo cardiac surgery, how does prothrombin complex concentrate (PCC) compare with fresh frozen plasma (FFP) or recombinant factor VIIa (rFVIIa)?",
            "gold_answer": "For people who have coagulopathic non\u2010surgical bleeding and who undergo cardiac surgery, PCC probably reduces the requirement of red blood cell (RBC) units transfused compared with FFP or rFVIIa. Moderate\u2010certainty evidence from RCTs shows that PCC probably reduces the RBC units transfused (by 0.9 units, all results on average) compared with FFP, with little to no difference between groups in intensive care length of stay and in absolute numbers of thrombotic events or 30\u2010day deaths, but based on underpowered estimations. Low\u2010certainty evidence from non\u2010randomized studies (NRSs) suggests that fewer people required RBC with PCC than with FFP (812 vs 889 per 1000 people); the effect observed among RCTs was similar; however, the range of statistical outcomes encompasses both positive and negative findings, limiting these results. RCTs suggest that there may be little to no difference in postoperative bleeding, absolute number of renal replacement therapy, or adverse events, but again, this was based on underpowered estimations. Moderate\u2010certainty evidence from NRSs shows that PCC probably reduces the RBC units transfused (by 5 units) compared with rFVIIa, but the certainty of evidence for other outcomes was very low, and no study assessed adverse events.",
            "gold_answer_terms": "CARDIAC (cardiac): related to the heart\nCELL (cell): The tiny building blocks which make up the organs and tissues of the body.\nRBC (rbc): red blood cell\nRCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nRENAL (renal): pertaining to the kidneys\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4213",
            "llm_answer": "For people with coagulopathic non-surgical bleeding who undergo cardiac surgery, prothrombin complex concentrate (PCC) is a better option compared to fresh frozen plasma (FFP) or recombinant factor VIIa (rFVIIa) for several reasons:\n1. Efficacy: PCC contains a higher concentration of active clotting factors, including prothrombin, factor II, and factor X, which are essential for blood clotting. This makes it more effective in reversing coagulopathy and controlling bleeding compared to FFP, which contains a lower concentration of clotting factors. rFVIIa, on the other hand, is a recombinant form of factor VIIa, which can also promote clotting, but its efficacy may be lower than PCC in certain situations.\n2. Safety: PCC is associated with a lower risk of transfusion-related complications, such as transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO), compared to FFP. rFVIIa can cause bleeding complications, especially when used in high doses or in patients with a history of stroke or brain injury.\n3. Dosing: PCC is available in a fixed dose, which makes it easier to administer and monitor, whereas FFP and rFVIIa require careful dosing based on the patient's weight and clinical status.\n4. Availability: PCC is widely available and can be easily stored and transported, whereas FFP requires frozen storage and has a limited shelf life. rFVIIa is also available, but its cost can be prohibitive in some cases.\n5. Monitoring: PCC can be easily monitored for its effectiveness using standard coagulation tests, such as the prothrombin time (PT) and partial thromboplastin time (PTT), whereas the effectiveness of FFP and rFVIIa can be more difficult to assess.\nIn summary, for patients with coagulopathic non-surgical bleeding undergoing cardiac surgery, PCC is a safer and more effective option compared to FFP or",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For people who have coagulopathic non\u2010surgical bleeding and who undergo cardiac surgery, how does prothrombin complex concentrate (PCC) compare with fresh frozen plasma (FFP) or recombinant factor VIIa (rFVIIa)?[/INST]",
            "topic1": [
                "heart circulation"
            ],
            "topic2": [],
            "year": 2023,
            "author": "Ciapponi, Agust\u00edn; Thapa, Bipin"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 232,
                            "score": 0.5,
                            "text": "For people with coagulopathic non-surgical bleeding who undergo cardiac surgery, prothrombin complex concentrate (PCC) is a better option compared to fresh frozen plasma (FFP) or recombinant factor VIIa (rFVIIa) for several reasons:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 236,
                            "end": 397,
                            "score": 0.5,
                            "text": "Efficacy: PCC contains a higher concentration of active clotting factors, including prothrombin, factor II, and factor X, which are essential for blood clotting.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 398,
                            "end": 552,
                            "score": 0.5,
                            "text": "This makes it more effective in reversing coagulopathy and controlling bleeding compared to FFP, which contains a lower concentration of clotting factors.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 553,
                            "end": 712,
                            "score": 0.5,
                            "text": "rFVIIa, on the other hand, is a recombinant form of factor VIIa, which can also promote clotting, but its efficacy may be lower than PCC in certain situations.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 716,
                            "end": 924,
                            "score": 0.5,
                            "text": "Safety: PCC is associated with a lower risk of transfusion-related complications, such as transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO), compared to FFP.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 925,
                            "end": 1057,
                            "score": 0.5,
                            "text": "rFVIIa can cause bleeding complications, especially when used in high doses or in patients with a history of stroke or brain injury.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1061,
                            "end": 1248,
                            "score": 0.5,
                            "text": "Dosing: PCC is available in a fixed dose, which makes it easier to administer and monitor, whereas FFP and rFVIIa require careful dosing based on the patient's weight and clinical status.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1252,
                            "end": 1397,
                            "score": 0.5,
                            "text": "Availability: PCC is widely available and can be easily stored and transported, whereas FFP requires frozen storage and has a limited shelf life.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1398,
                            "end": 1470,
                            "score": 0.5,
                            "text": "rFVIIa is also available, but its cost can be prohibitive in some cases.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1474,
                            "end": 1719,
                            "score": 0.5,
                            "text": "Monitoring: PCC can be easily monitored for its effectiveness using standard coagulation tests, such as the prothrombin time (PT) and partial thromboplastin time (PTT), whereas the effectiveness of FFP and rFVIIa can be more difficult to assess.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4213_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1720,
                            "end": 1873,
                            "score": 0.5,
                            "text": "In summary, for patients with coagulopathic non-surgical bleeding undergoing cardiac surgery, PCC is a safer and more effective option compared to FFP or",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4090",
            "question": "How does ocrelizumab compare with placebo for adults with primary progressive multiple sclerosis?",
            "gold_answer": "Low\u2010 to moderate\u2010certainty evidence suggests that clinicians may consider ocrelizumab as an effective and safe treatment option for adults with primary progressive multiple sclerosis. People with primary progressive multiple sclerosis (PPMS) experience symptoms that worsen gradually. Low\u2010certainty evidence suggests that fewer people experienced disability progression by \u2265 120 weeks with ocrelizumab than with placebo (296 vs 357 per 1000 people; all results on average). Moderate\u2010certainty evidence shows that likely more people experienced any adverse events with ocrelizumab compared with placebo (951 vs 900 per 1000 people), while low\u2010certainty evidence suggests there was little or no difference between groups in number of serious adverse events experienced or number of participants who discontinued treatment due to adverse events (204 vs 222 per 1000 people and 41 vs 33 per 1000 people, respectively). Further low\u2010certainty evidence suggests there was a lower mean percentage change in brain volume in favor of ocrelizumab. It was not applicable to measure number of participants experiencing at least one relapse in this review on PPMS. No trials assessed the number of participants with gadolinium\u2010enhancing T1 lesions or with new or newly enlarged T2\u2010hyperintense lesions on magnetic resonance imaging (MRI). For a comparison of ocrelizumab with interferon beta\u20101a for adults with relapsing\u2010remitting multiple sclerosis, see CCA 4091 .",
            "gold_answer_terms": "SYMPTOM (symptom): A specific medical sign of a condition, illness or disease.\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nRELAPSE (relapse): the return of a disease\nASSESS (assess): to learn about, measure, evaluate, look at\nLESION (lesion): wound or injury; a diseased patch of skin\nMRI (mri): magnetic resonance imaging, diagnostic pictures of the inside of the body, created using magnetic rather than x-ray energy\nINTERFERON (interferon): drug which acts against viruses; antiviral agent",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4090",
            "llm_answer": "Ocrelizumab has been shown to be effective in slowing down the progression of primary progressive multiple sclerosis (PPMS) compared to placebo. In a clinical trial, ocrelizumab significantly reduced the rate of progression of disability compared to placebo, as measured by the Expanded Disability Status Scale (EDSS). Additionally, ocrelizumab also showed a significant reduction in the number of new or enlarging lesions on MRI scans compared to placebo. However, it's important to note that ocrelizumab is not a cure for PPMS, and it does not reverse existing disability.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> How does ocrelizumab compare with placebo for adults with primary progressive multiple sclerosis?[/INST]",
            "topic1": [
                "neurology"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Antonio\u2010Santos, Aileen A."
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4090_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4090_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 144,
                            "score": 0.5,
                            "text": "Ocrelizumab has been shown to be effective in slowing down the progression of primary progressive multiple sclerosis (PPMS) compared to placebo.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4090_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 145,
                            "end": 318,
                            "score": 0.5,
                            "text": "In a clinical trial, ocrelizumab significantly reduced the rate of progression of disability compared to placebo, as measured by the Expanded Disability Status Scale (EDSS).",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4090_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 319,
                            "end": 456,
                            "score": 0.5,
                            "text": "Additionally, ocrelizumab also showed a significant reduction in the number of new or enlarging lesions on MRI scans compared to placebo.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4090_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 457,
                            "end": 574,
                            "score": 0.5,
                            "text": "However, it's important to note that ocrelizumab is not a cure for PPMS, and it does not reverse existing disability.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4090",
            "question": "How does ocrelizumab compare with placebo for adults with primary progressive multiple sclerosis?",
            "gold_answer": "Low\u2010 to moderate\u2010certainty evidence suggests that clinicians may consider ocrelizumab as an effective and safe treatment option for adults with primary progressive multiple sclerosis. People with primary progressive multiple sclerosis (PPMS) experience symptoms that worsen gradually. Low\u2010certainty evidence suggests that fewer people experienced disability progression by \u2265 120 weeks with ocrelizumab than with placebo (296 vs 357 per 1000 people; all results on average). Moderate\u2010certainty evidence shows that likely more people experienced any adverse events with ocrelizumab compared with placebo (951 vs 900 per 1000 people), while low\u2010certainty evidence suggests there was little or no difference between groups in number of serious adverse events experienced or number of participants who discontinued treatment due to adverse events (204 vs 222 per 1000 people and 41 vs 33 per 1000 people, respectively). Further low\u2010certainty evidence suggests there was a lower mean percentage change in brain volume in favor of ocrelizumab. It was not applicable to measure number of participants experiencing at least one relapse in this review on PPMS. No trials assessed the number of participants with gadolinium\u2010enhancing T1 lesions or with new or newly enlarged T2\u2010hyperintense lesions on magnetic resonance imaging (MRI). For a comparison of ocrelizumab with interferon beta\u20101a for adults with relapsing\u2010remitting multiple sclerosis, see CCA 4091 .",
            "gold_answer_terms": "SYMPTOM (symptom): A specific medical sign of a condition, illness or disease.\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nRELAPSE (relapse): the return of a disease\nASSESS (assess): to learn about, measure, evaluate, look at\nLESION (lesion): wound or injury; a diseased patch of skin\nMRI (mri): magnetic resonance imaging, diagnostic pictures of the inside of the body, created using magnetic rather than x-ray energy\nINTERFERON (interferon): drug which acts against viruses; antiviral agent",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4090",
            "llm_answer": "Ocrelizumab is a medication that has been shown to be effective in treating primary progressive multiple sclerosis (PPMS) in clinical trials. Compared to placebo, ocrelizumab has been shown to significantly reduce the number of relapses in patients with PPMS, as well as slow the progression of disability. Additionally, ocrelizumab has been shown to reduce inflammation in the brain and spinal cord, which is a hallmark of MS. However, it's important to note that ocrelizumab is not a cure for MS, and it's not a guarantee that patients will experience no relapses or disability progression. It's also important to note that like any medication, ocrelizumab can have side effects, and patients should discuss the potential benefits and risks with their healthcare provider.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> How does ocrelizumab compare with placebo for adults with primary progressive multiple sclerosis?[/INST]",
            "topic1": [
                "neurology"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Antonio\u2010Santos, Aileen A."
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4090_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4090_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 141,
                            "score": 0.5,
                            "text": "Ocrelizumab is a medication that has been shown to be effective in treating primary progressive multiple sclerosis (PPMS) in clinical trials.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4090_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 142,
                            "end": 306,
                            "score": 0.5,
                            "text": "Compared to placebo, ocrelizumab has been shown to significantly reduce the number of relapses in patients with PPMS, as well as slow the progression of disability.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4090_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 307,
                            "end": 427,
                            "score": 0.5,
                            "text": "Additionally, ocrelizumab has been shown to reduce inflammation in the brain and spinal cord, which is a hallmark of MS.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4090_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 428,
                            "end": 592,
                            "score": 0.5,
                            "text": "However, it's important to note that ocrelizumab is not a cure for MS, and it's not a guarantee that patients will experience no relapses or disability progression.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4090_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 593,
                            "end": 774,
                            "score": 0.5,
                            "text": "It's also important to note that like any medication, ocrelizumab can have side effects, and patients should discuss the potential benefits and risks with their healthcare provider.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.1303",
            "question": "What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?",
            "gold_answer": "High\u2010quality evidence shows that children and adults with a clinical diagnosis of tuberculosis (TB) meningitis receiving an anti\u2010TB regimen are less likely to die within 24 months when an adjunctive corticosteroid is administered (312 versus 413 per 1000 people died with an adjunctive corticosteroid compared with no corticosteroid, respectively). Moderate\u2010quality evidence showed that this benefit was not sustained in the longer\u2010term (5 years). Low\u2010quality evidence suggests there was no benefit of an adjunctive corticosteroid in terms of reducing rates of disabling neurological deficit, ether within 24 months or at 5 years. There was no apparent impact of adjunctive corticosteroids on the incidences of hepatitis, hyperglycemia/glycosuria, gastrointestinal bleeding, or invasive bacterial infection but event rates were very low meaning conclusions cannot be drawn.",
            "gold_answer_terms": "CLINICAL (clinical): pertaining to medical care\nDIAGNOSIS (diagnosis): The way a medical professional recognises a condition or disease.\nMENINGITIS (meningitis): Inflammation in the brain caused by a virus or bacteria.\nREGIMEN (regimen): pattern of giving treatment\nCORTICOSTEROIDS (corticosteroids): A group of hormones which may be used to suppress the body\u2019s immune response or to reduce inflammation. Also used during pregnancy in women who are thought may have their baby prematurely. They reduce the chance of the baby having problems from being born prematurely. See also steroids.\nTERM (term): Between 37 and 42 weeks of pregnancy.\nNEUROLOGICAL (neurological): pertaining to the nervous system\nGASTROINTESTINAL (gastrointestinal): Relating to the stomach and intestine.\nINVASIVE (invasive): A medical procedure when a cut is made to the body or an instrument is inserted.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.1303",
            "llm_answer": "Adjunctive corticosteroids have been shown to improve mortality and disability outcomes in people with tuberculous meningitis. Studies have consistently demonstrated that corticosteroids reduce the risk of death and disability in patients with tuberculous meningitis, particularly in those with severe disease. The use of corticosteroids has been associated with a significant reduction in mortality rates, from approximately 30-40% in untreated patients to around 10-20% in patients receiving corticosteroids. Additionally, corticosteroids have been shown to reduce the risk of long-term disability, such as hearing loss and cognitive impairment. However, the optimal dosage and duration of corticosteroid therapy for tuberculous meningitis are still uncertain and require further research.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?[/INST]",
            "topic1": [
                "child health",
                "infectious disease",
                "lungs airways"
            ],
            "topic2": [
                "respiratory infections"
            ],
            "year": 2016,
            "author": "Burch, Jane; Eisenhut, Michael"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 126,
                            "score": 0.5,
                            "text": "Adjunctive corticosteroids have been shown to improve mortality and disability outcomes in people with tuberculous meningitis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 127,
                            "end": 310,
                            "score": 0.5,
                            "text": "Studies have consistently demonstrated that corticosteroids reduce the risk of death and disability in patients with tuberculous meningitis, particularly in those with severe disease.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 311,
                            "end": 510,
                            "score": 0.5,
                            "text": "The use of corticosteroids has been associated with a significant reduction in mortality rates, from approximately 30-40% in untreated patients to around 10-20% in patients receiving corticosteroids.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 511,
                            "end": 647,
                            "score": 0.5,
                            "text": "Additionally, corticosteroids have been shown to reduce the risk of long-term disability, such as hearing loss and cognitive impairment.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 648,
                            "end": 791,
                            "score": 0.5,
                            "text": "However, the optimal dosage and duration of corticosteroid therapy for tuberculous meningitis are still uncertain and require further research.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.1303",
            "question": "What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?",
            "gold_answer": "High\u2010quality evidence shows that children and adults with a clinical diagnosis of tuberculosis (TB) meningitis receiving an anti\u2010TB regimen are less likely to die within 24 months when an adjunctive corticosteroid is administered (312 versus 413 per 1000 people died with an adjunctive corticosteroid compared with no corticosteroid, respectively). Moderate\u2010quality evidence showed that this benefit was not sustained in the longer\u2010term (5 years). Low\u2010quality evidence suggests there was no benefit of an adjunctive corticosteroid in terms of reducing rates of disabling neurological deficit, ether within 24 months or at 5 years. There was no apparent impact of adjunctive corticosteroids on the incidences of hepatitis, hyperglycemia/glycosuria, gastrointestinal bleeding, or invasive bacterial infection but event rates were very low meaning conclusions cannot be drawn.",
            "gold_answer_terms": "CLINICAL (clinical): pertaining to medical care\nDIAGNOSIS (diagnosis): The way a medical professional recognises a condition or disease.\nMENINGITIS (meningitis): Inflammation in the brain caused by a virus or bacteria.\nREGIMEN (regimen): pattern of giving treatment\nCORTICOSTEROIDS (corticosteroids): A group of hormones which may be used to suppress the body\u2019s immune response or to reduce inflammation. Also used during pregnancy in women who are thought may have their baby prematurely. They reduce the chance of the baby having problems from being born prematurely. See also steroids.\nTERM (term): Between 37 and 42 weeks of pregnancy.\nNEUROLOGICAL (neurological): pertaining to the nervous system\nGASTROINTESTINAL (gastrointestinal): Relating to the stomach and intestine.\nINVASIVE (invasive): A medical procedure when a cut is made to the body or an instrument is inserted.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.1303",
            "llm_answer": "Adjunctive corticosteroids have been found to improve mortality and disability outcomes in people with tuberculous meningitis. According to a systematic review and meta-analysis published in the Cochrane Database of Systematic Reviews, corticosteroids reduced the risk of death and disability in patients with tuberculous meningitis by 27% and 23%, respectively, compared to those who did not receive corticosteroids. However, the review also noted that the quality of the evidence was generally low and that further research is needed to confirm these findings. It's important to note that corticosteroids should only be used under the guidance of a healthcare professional and in conjunction with appropriate antituberculous therapy.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?[/INST]",
            "topic1": [
                "child health",
                "infectious disease",
                "lungs airways"
            ],
            "topic2": [
                "respiratory infections"
            ],
            "year": 2016,
            "author": "Burch, Jane; Eisenhut, Michael"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 126,
                            "score": 0.5,
                            "text": "Adjunctive corticosteroids have been found to improve mortality and disability outcomes in people with tuberculous meningitis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 127,
                            "end": 417,
                            "score": 0.5,
                            "text": "According to a systematic review and meta-analysis published in the Cochrane Database of Systematic Reviews, corticosteroids reduced the risk of death and disability in patients with tuberculous meningitis by 27% and 23%, respectively, compared to those who did not receive corticosteroids.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 418,
                            "end": 562,
                            "score": 0.5,
                            "text": "However, the review also noted that the quality of the evidence was generally low and that further research is needed to confirm these findings.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 563,
                            "end": 735,
                            "score": 0.5,
                            "text": "It's important to note that corticosteroids should only be used under the guidance of a healthcare professional and in conjunction with appropriate antituberculous therapy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.2493",
            "question": "Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?",
            "gold_answer": "Reviewers found no conclusive RCT evidence suggesting that administration of probiotics to pregnant women was superior or inferior to placebo in reducing morbidity or mortality in preterm infants. Low\u2010certainty evidence suggests that in pregnant women who received probiotics, the risk of preterm birth (< 37 weeks) and miscarriage/stillbirth was no more or less likely compared with those who did not receive probiotics. Only one RCT (159 infants) reported no incidences of early neonatal sepsis (\u2264 3 days) in either trial arm. For most outcomes, event rates were very low or there were no events in both arms. There is a lack of data on neonatal short\u2010term (early or late sepsis, necrotizing enterocolitis, neonatal death, hospital stay) and long\u2010term (major neurodevelopmental disability) potential benefits or harms following probiotic administration. None of the trials included women with a previous history of preterm birth, multiple pregnancy, or uterine anomaly. Reviewers did not assess serious adverse maternal or neonatal adverse events following use of probiotics.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nMORBIDITY (morbidity): undesired result or complication\nMORTALITY (mortality): death\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nSEPSIS (sepsis): The immune system's overreaction to an infection or injury which can lead to tissue damage, organ failure, and death.\nPOTENTIAL (potential): possible\nPOTENTIATE (potentiate): increase or multiply the effect of a drug or toxin (poison) by giving another drug or toxin at the same time (sometimes an unintentional result)\nPOTENTIATOR (potentiator): an agent that helps another agent work better\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.2493",
            "llm_answer": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants. Studies have found that probiotics can help reduce the risk of preterm birth, necrotizing enterocolitis, and other complications in preterm infants. However, it's important to note that the efficacy of probiotics may vary depending on the specific strain and dosage used, and more research is needed to fully understand their benefits and potential risks. It's recommended to consult with a healthcare provider before taking probiotics during pregnancy.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2019,
            "author": "Kamath, Mohan S"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 122,
                            "score": 0.5,
                            "text": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 123,
                            "end": 271,
                            "score": 0.5,
                            "text": "Studies have found that probiotics can help reduce the risk of preterm birth, necrotizing enterocolitis, and other complications in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 272,
                            "end": 478,
                            "score": 0.5,
                            "text": "However, it's important to note that the efficacy of probiotics may vary depending on the specific strain and dosage used, and more research is needed to fully understand their benefits and potential risks.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 479,
                            "end": 576,
                            "score": 0.5,
                            "text": "It's recommended to consult with a healthcare provider before taking probiotics during pregnancy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.2493",
            "question": "Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?",
            "gold_answer": "Reviewers found no conclusive RCT evidence suggesting that administration of probiotics to pregnant women was superior or inferior to placebo in reducing morbidity or mortality in preterm infants. Low\u2010certainty evidence suggests that in pregnant women who received probiotics, the risk of preterm birth (< 37 weeks) and miscarriage/stillbirth was no more or less likely compared with those who did not receive probiotics. Only one RCT (159 infants) reported no incidences of early neonatal sepsis (\u2264 3 days) in either trial arm. For most outcomes, event rates were very low or there were no events in both arms. There is a lack of data on neonatal short\u2010term (early or late sepsis, necrotizing enterocolitis, neonatal death, hospital stay) and long\u2010term (major neurodevelopmental disability) potential benefits or harms following probiotic administration. None of the trials included women with a previous history of preterm birth, multiple pregnancy, or uterine anomaly. Reviewers did not assess serious adverse maternal or neonatal adverse events following use of probiotics.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nMORBIDITY (morbidity): undesired result or complication\nMORTALITY (mortality): death\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nSEPSIS (sepsis): The immune system's overreaction to an infection or injury which can lead to tissue damage, organ failure, and death.\nPOTENTIAL (potential): possible\nPOTENTIATE (potentiate): increase or multiply the effect of a drug or toxin (poison) by giving another drug or toxin at the same time (sometimes an unintentional result)\nPOTENTIATOR (potentiator): an agent that helps another agent work better\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.2493",
            "llm_answer": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants. Probiotics are beneficial bacteria that can help maintain a healthy gut microbiome, which is important for the development and function of various bodily systems, including the immune system.\nStudies have found that probiotics can help reduce the risk of preterm birth, which is a leading cause of neonatal morbidity and mortality. Probiotics have also been shown to reduce the risk of other complications in preterm infants, such as necrotizing enterocolitis, a serious condition that can cause damage to the intestines.\nIt's important to note that not all probiotics are the same, and some strains have been found to be more effective than others in preventing morbidity and mortality in preterm infants. For example, the probiotic strain Lactobacillus rhamnosus GG has been shown to be effective in reducing the risk of necrotizing enterocolitis.\nIt's important to consult with a healthcare provider before taking any supplements during pregnancy, including probiotics, to ensure safety and effectiveness. Additionally, it's important to note that while probiotics can help reduce the risk of complications, they are not a guarantee against them, and other factors such as proper prenatal care, a healthy diet, and a safe delivery are also important for a healthy pregnancy and baby.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2019,
            "author": "Kamath, Mohan S"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 122,
                            "score": 0.5,
                            "text": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 123,
                            "end": 314,
                            "score": 0.5,
                            "text": "Probiotics are beneficial bacteria that can help maintain a healthy gut microbiome, which is important for the development and function of various bodily systems, including the immune system.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 315,
                            "end": 454,
                            "score": 0.5,
                            "text": "Studies have found that probiotics can help reduce the risk of preterm birth, which is a leading cause of neonatal morbidity and mortality.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 455,
                            "end": 644,
                            "score": 0.5,
                            "text": "Probiotics have also been shown to reduce the risk of other complications in preterm infants, such as necrotizing enterocolitis, a serious condition that can cause damage to the intestines.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 645,
                            "end": 829,
                            "score": 0.5,
                            "text": "It's important to note that not all probiotics are the same, and some strains have been found to be more effective than others in preventing morbidity and mortality in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 830,
                            "end": 972,
                            "score": 0.5,
                            "text": "For example, the probiotic strain Lactobacillus rhamnosus GG has been shown to be effective in reducing the risk of necrotizing enterocolitis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 973,
                            "end": 1131,
                            "score": 0.5,
                            "text": "It's important to consult with a healthcare provider before taking any supplements during pregnancy, including probiotics, to ensure safety and effectiveness.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1132,
                            "end": 1409,
                            "score": 0.5,
                            "text": "Additionally, it's important to note that while probiotics can help reduce the risk of complications, they are not a guarantee against them, and other factors such as proper prenatal care, a healthy diet, and a safe delivery are also important for a healthy pregnancy and baby.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    }
]